Clinical trial report: TMC278 (Rilpivirine) versus efavirenz as initial therapy in treatment-Naïve, HIV-1-infected patients

Rodger D. MacArthur

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical trial report: TMC278 (Rilpivirine) versus efavirenz as initial therapy in treatment-Naïve, HIV-1-infected patients'. Together they form a unique fingerprint.